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INHIBITION OF PHAGOCYTE KILLING OF BACTERIA VIA 
INHIBITORY IGG-FCR SIGNALING 
By 
 
EKOW AMBAAH 
 
 
ABSTRACT 
 
Sepsis is among the leading causes of death in health facilities worldwide. Even with 
adequate treatment, severe sepsis results in approximately 50% mortality, which indicates 
that the individual response to the infection is variable. (Moitra, Beal, Belikoff, & 
Remick, 2012) 
In a previous paper published by the Remick laboratory it was determined that the 
presence of pre-existing, plasma IgG antibodies in mice prior to the onset of sepsis could 
be responsible for differences in their survival. A Plasma Enhanced Killing (PEK) assay 
was used to calculate the PEK capacity of plasma i.e. the ability of plasma to augment 
phagocyti c killing of bacteria. PEK was calculated as PEK= (1/log (N)) X 100; where 
N= number of surviving bacteria; a higher PEK indicated better bacterial killing(Moitra 
et al., 2012). The prior study also determined that inhibitory IgG probably binds 
inhibitory Fc receptors on phagocytic cells to result in reduced killing of bacteria. 
This published work used the value of the PEK to predict which mice would live and 
which mice would die when subjected to sepsis from cecal bacteria through the method 
of cecal ligation and puncture (CLP) to induce sepsis. 
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The goal of this study was to build on what was already found and go further to 
demonstrate the pathway of how the blocking of IgG occurs via the FcgR in bacteria. In 
prior experiments by the Remick lab it was determined that the plasma from the in vitro 
plasma enhanced killing assay was related to the survival status of septic mice subjected 
to cecal ligation and puncture (CLP) model of bacterial peritonitis. The PEK assay relies 
on the presence of pre-existing antibodies in the plasma augmenting the killing of 
bacterial cells by polymorphonuclear cells. A high PEK value mean the plasma had the 
capability to kill bacteria and the mice were more likely to survive compared to those 
with a lower PEK value who were more likely to die from sepsis. 
Two sets of plasma were used, plasma collected with Ethylenediaminetetraacetic acid 
(EDTA) and plasma collected with heparin as anticoagulants. The data showed the likely 
presence of inhibitory IgG to be present more in the plasma sample collected with 
heparin than in those collected with EDTA. 
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INTRODUCTION 
 
 
1.1 Sepsis introduction  
 
Today sepsis is defined as “a life-threatening organ dysfunction caused by a dysregulated 
host response to infection”(Singer et al., 2016). The word sepsis is of Greek origin and its 
believed to have originated over 2700 years ago and defined as “decomposition of animal 
or vegetable organic matter in the presence of bacteria” (Namas et al., 2012). The Greeks 
also thought of sepsis as relating to rot, decay or putrefaction(Vincent, Opal, Marshall, & 
Tracey, 2013).  
  2  
  
Figure 1  New terms and definitions for sepsis- adapter from Singer et al, 
2016(Singer et al., 2016) 
Sepsis as a condition is not easy to diagnose and is also equally hard to treat. Sepsis is 
more of a syndrome and not just a disease(Vincent et al., 2013) . The term sepsis is not 
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used for any ordinary infection but rather for patients who are really sick and have some 
degree of organ dysfunction who have to be admitted to the ICU and monitored 
carefully(Vincent et al., 2013). A diagnosis of sepsis is arrived at by the exclusion of 
other conditions that may manifest in like manner. The diagnosis is arrived at by using 
several findings; general malaise and can include various, signs such as, fever, 
hypotension, tachycardia, dyspnea. Some patients may present with an impaired mental 
status or can present with mottled skin and increased capillary filling time. Laboratory 
findings may include, electrolyte imbalances, coagulation abnormalities, elevated lactate 
and blood gas abnormalities, impaired renal and kidney and liver function tests, and there 
may be increased C-reactive protein.(Cecconi, Evans, Levy, & Rhodes, 2018) 
 
Singer et al in 2016 described the criteria agreed upon at The Third International 
Consensus Definitions for Sepsis and Septic Shock that adopted the Sequential Organ 
Failure Assessment (SOFA) score that included parameters to assess; central nervous 
system, cardiovascular system, respiratory system, hepatic system, renal system and the 
body’s coagulation metrics. Also, a new measure qSOFA (for quick SOFA) which 
focused on altered mentation, systolic blood pressure of 100 mm Hg or less, and 
respiratory rate of 22/min or greater. This provides a simple bedside criteria to identify 
patients with suspected infection who are likely to have poor outcomes.(Singer et al., 
2016),(Churpek et al., 2017) 
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Table 1. Sequential (Sepsis-Related) Organ Function Assessment Score 
Adapted from Singer et al, 2016 (Singer et al., 2016) 
 
1.2 Epidemiology of sepsis 
In the United States, close to one million cases of sepsis are admitted every year, and the 
numbers keep increasing year over year. About an 8.7% rise has been observed in the 
incidence of sepsis among hospitalized patients in the US over a period of two decades. 
Also sepsis is responsible for more over 50% of hospital deaths(Paoli, Reynolds, Sinha, 
Gitlin, & Crouser, 2018) and according to Greg S. Martin, mortality increases in relation 
to the stage of the patient’s sepsis. There is an estimated  10–20% mortality for sepsis, 
20–40% for severe sepsis, and 40–80% for septic shock(Martin, 2012). The majority of 
patients with sepsis are admitted to the intensive care units and many are put on 
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mechanical ventilation. The estimated annual costs for treating patients with sepsis is 
projected to exceed $17 billion. (Ward & Bosmann, 2012),(Novosad et al., 2016) 
 
The average length of stay (LOS) for sepsis patients hospitalized in the US is about 75% 
more than that of most other conditions (5), and the average LOS in 2013 was reportedly 
to correlated to the severity of sepsis : 4.5 days for sepsis, 6.5 days for severe sepsis, and 
16.5 days for septic shock(Paoli et al., 2018). 
 
 In the year 2013, sepsis accounted for over $24 billion in hospital expenses, making up 
13% of total U.S. hospital costs, and yet this represented 3.6% of hospital stays. The 
hospital costs for treating sepsis are currently more than twice those of other conditions 
and this continues to grow at a rate of three times that of other admissions(Paoli et al., 
2018),(Novosad et al., 2016).  
 
It is important to understand that sepsis mortality is based on 28-day survival, whereas 
most mortality studies, for diseases such as cancer, are based on a 5-year survival. As 
such, in addition to the high lethality of sepsis, it also accounts for a significant number 
of years of life lost(Remick, 2007). 
 
  6  
  
1.3 Treatment of sepsis 
The management of sepsis has to be undertaken as a medical emergency. Screening 
patients for signs and symptoms of sepsis, early diagnosis and focused effective and 
timely intervention, is needed to reduce both mortality and morbidity. A thorough and 
aggressive assessment for a hidden source of infection, such as an undrained abscess, 
through appropriate laboratory testing and imaging is essential to the initial management 
of sepsis. Additionally, early initiation of appropriate antimicrobial therapy, ensuring 
adequate tissue perfusion via fluid resuscitation, and advanced interventions as guided by 
diagnosis and assessment of the patient are part of initial management of sepsis.  
Guidelines and education alone are unlikely to make significant impacts on behavioral 
change, but multifaceted interventions have been shown to be effective compared to a 
single intervention and instrumental also in influencing behavioral change. The Surviving 
Sepsis Campaign’s multifaceted approach to intervention used local interdisciplinary 
teams, education materials, and audit and feedback of bedside compliance. According to 
Cecconi et al “a study published in 2014 showed that an improved compliance with the 
resuscitation bundle was associated with a 9.6% absolute decline in mortality. This 
increased compliance was associated with a statistically significant decrease in mortality 
that was even greater in hospitals with high compliance versus low compliance”(Cecconi 
et al., 2018),(Coopersmith et al., 2018). 
 
The Surviving Sepsis Campaign (SSC), is a global initiative that strives to improve 
survival in patients with sepsis. The research continues for better diagnostic techniques 
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that can lead to individualized management regiments, and for effective pharmacological 
management of the disease process(Cecconi et al., 2018),(Coopersmith et al., 2018). 
 
1.4 Pathophysiology 
The process of sepsis has been studied extensively, yet its pathophysiology has not been 
fully explained. Some of the explanations assigned to it are still theoretical although some 
have very good experimental evidence to support the reasoning.  
Pro-inflammatory and anti-inflammatory responses coexist in sepsis and can result in the 
suppression of the immune system. The response that predominates in the clinical 
presentation varies from patient to patient and over time in each patient(Vincent et al., 
2013). 
 
1.4.1 Coagulopathy 
The inflammatory process during sepsis causes significant changes to occur at multiple 
levels within both the coagulation system and the cells that regulate the coagulation 
system. During sepsis, the activation of coagulation is widespread and is induced by 
pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS) and 
exotoxins, this leads to microvascular thrombosis, hypoperfusion, and ultimately Multiple 
Organ Dysfunction Syndrome (MODS), and eventually death. It is presumed that the 
coagulation cascade is mediated by the expression of tissue factor (TF) on monocytes and 
macrophages, and by the TF-expressing microparticles from platelets, monocytes, and 
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macrophages. The vascular endothelial cells are damaged which then results in leakage 
and DIC.(Tsao, Ho, & Wu, 2015),(van der Poll & Opal, 2008),(Cohen, 2002) 
 
Although the coagulopathy is systemic and widespread, the bleeding is typically limited 
to select sites. The underlying cause of coagulopathy with respect to the clotting system, 
the white blood cells and the endothelium, is multifactorial. In septic patients Virchow’s 
triad of abnormal blood flow, changes in coagulation and endothelial injury exist and 
result in reduced perfusion of vital organs. Various anticoagulant components on the 
surface of endothelial cells are reduced in sepsis. Specifically, antithrombin, protein C , 
and tissue factor pathway inhibitor , are decreased. Their reduction is associated with a 
poor prognosis(Remick, 2007),(Tsao et al., 2015). 
 
A study conducted in 2014 demonstrated improvement in coagulation and fibrinolytic 
parameters in septic shock patients in whom glycemic control was achieved  within 24 
hours as compared to patients who were normoglycemic(Sanches et al., 2014) 
 
1.4.2 Stress Hyperglycemia 
 Several experimental studies have demonstrated that hyperglycemia is related to an 
increased inflammatory response, oxidative stress, and the down-regulation of innate 
immunity(Sanches et al., 2014).  
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The stress associated with a critical illness is characterized by the activation of the 
hypothalamic–pituitary–adrenal axis and the release of cortisol. 
 
Additionally, there is increased release of norepinephrine and epinephrine as well as 
glucagon and growth hormone. Interleukin-1 (IL-1) and tumor necrosis factor-a (TNF - 
a) inhibit insulin release and cause insulin resistance. The low to normal insulin levels 
plus the insulin resistance that occurs in the presence of increased secretion of counter 
regulatory hormones leads to stress hyperglycemia.  Hyperglycemia facilitates an 
environment that is pro-inflammatory(Marik & Raghavan, 2004). 
 
The physiology of “stress hyperglycemia” is much different from that type II diabetes. In 
type II diabetes, hyperglycemia is caused by a combination of insulin resistance and 
defective secretion of insulin by pancreatic β-cells. In stress hyperglycemia, complex 
interactions occur between counter-regulatory hormones and cytokines leading to an 
excessive and un-inhibitable production of glucose associated with insulin resistance of 
the tissues where glucose uptake is insulin dependent. The degree of insulin resistance in 
a septic patient is directly proportional to the severity of the patient’s stress response. 
Stress causes an increase in the hepatic output of glucose from glycogenolysis and 
gluconeogenesis. Glycogenolysis is primarily triggered by catecholamines and sustained 
under the effects of epinephrine and cortisol. Gluconeogenesis happens to be triggered to 
a larger extent by glucagon than by epinephrine and cortisol. Among the various 
inflammatory mediators released in the acutely ill, (TNF-α) probably promotes 
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gluconeogenesis by stimulating glucagon production(Marik & Raghavan, 2004), (Preiser, 
Thooft, & Tironi, 2016). Patients who were subjected to intensive glycemic control had a 
reduced inflammation and decreased incidence of bacteremia(Sanches et al., 2014).  
 
To the contrary however a study conducted by  investigators from several countries 
which compared intensive glycemic control to conventional glycemic control in 6104 
patients found that when the blood sugar level was less that 180md/dl more patients 
survived than those whose blood sugar was maintained between 81 and 108mg/dl. Those 
who received the intensive glycemic control were more likely to develop hypoglycemia 
and it was found that most of those that died was due to cardiovascular failure.(Finfer, 
Simon, Chittock, Dean R., Su, Yu-Shuo Steve, Blair, Deborah, Foster, Denise, Dhingra, 
Vinay, Bellomo, Rinaldo, Cook, Deborah, 2009) ‘A study conducted in 2012 on patients 
with sepsis found those with stress hyperglycemia to have a lower  ICU mortality than 
those without stress hyperglycemia, although they found this relationship, they did not 
find or assign a reason for this finding(Tiruvoipati et al., 2012). 
 
1.4.3 Lung injury 
Sepsis is the most common systemic cause of acute lung injury (ALI) with a sophisticated 
patho-physiology, where the systemic inflammatory response results in multiple organ 
dysfunctions. Sepsis is the predominant risk factor in the development of ALI and well 
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over 50% of patients in the ICU with sepsis develop ALI(Sevransky et al., 2009), 
(Choudhury et al., 2015). 
 
ALI is marked by increased lung microvascular permeability leading to the leakage of 
protein- rich edema fluid and circulating inflammatory cells into the pulmonary 
interstitium and air spaces. Bacterial endotoxins assist the activated neutrophil to adhere 
to the endothelial cells, and the excess expression of intercellular adhesion molecule-1 
(ICAM-1) aids the recruitment of more neutrophils resulting in the loss of endothelial 
integrity. Evidence suggests that septic lung tissue contains considerable amounts of pro-
inflammatory cytokines like TNF-α and IL-1β. The activated neutrophil produces a large 
quantity of reactive oxygen and nitrogen species leading to oxidative and nitrosative 
stress during ALI. Excessive NO production through iNOS enhances microvascular 
protein leak and induces the expression of IL-1and TNF-α(Choudhury et al., 2015). 
 
The end result of these changes are, perfusion-ventilation mismatch, arterial hypoxemia, 
and reduced lung compliance: Acute respiratory distress syndrome (ARDS) usually 
requires the use of mechanical ventilation, which  can further injure the lungs and 
promote systemic inflammation(Gotts & Matthay, 2016). 
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1.4.4 Renal injury 
In earlier experimental work on septic Acute Kidney Injury (AKI), the global Renal 
Blood Flow (RBF) was shown to have decreased after the administration of an 
endotoxin. These endotoxin-based experiments led to the assumption that human septic 
AKI was due to renal vasoconstriction and ischemia(Schrier & Wang, 2004), (Bellomo 
et al., 2017). 
However, recently studies of hyperdynamic sepsis have shown that the renal circulation 
contributes to the systemic vasodilatation of sepsis. Therefore, in such models, septic 
AKI develops even in the presence of increased RBF. More recent evidence validates 
the view that in septic AKI, there is redistribution of blood flow away from the renal 
medulla to the renal cortex with some degree of medullary deoxygenation. The change 
in the regional distribution of blood flow implies that there is activation of intrarenal 
shunting pathway(Bellomo et al., 2017). 
According to a review article by Gomez et al 2016, recent evidence suggests that the 
origin of most cases of AKI are multifactorial and that several mechanisms may be at 
work. They further state that, “These mechanisms include inflammation, profound, 
heterogeneous distortion of peritubular and glomerular microvascular flow, and the 
tubular epithelial cell metabolic response to injury”(Gómez & Kellum, 2016). 
Additionally, studies in septic animals and postmortem examinations in septic humans 
have shown that sepsis-induced AKI is characterized by remarkably bland histology with 
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focal areas of tubular injury, but minimal cell death, suggesting that acute tubular 
necrosis does not explain this characteristic. Consistent in all these observations, 
regardless of the species, the disease stage, the severity, or the organ examined, there 
appears to be three distinct alterations: diffuse microcirculatory flow abnormalities, 
inflammation, and cellular bioenergetic responses to injury(Gómez & Kellum, 2016). Our 
understanding of the pathophysiology of acute kidney injury still remains limited and 
mostly is based on animal models(Bellomo et al., 2017). 
 
1.4.5 How phagocytes kill microbes 
Phagocytes are cells that are specialized for destruction, they include neutrophils and 
monocyte-macrophages. The name phagocyte describes their function of ingesting large 
particles (larger than 0.5 µm in diameter). Bacteria are destroyed by a process call 
phagocytosis, this is a process by which the bacteria is ingested or internalized into the 
phagocyte inside a cytoplasmic vesicle called the phagocytic vesicle. Microorganisms are 
killed by all types of phagocytes. The phagocytes tend to kill different types of pathogens. 
Neutrophils respond to bacterial and fungal infections and macrophages in addition to 
killing microbes also remove dead tissues and play a role in tissue repair(Gabig & Babior, 
1981), (Abbas, Abdul K, Litchman, Andrew H, Pillai, 2016),(Gordon, 2016). 
 
Phagocytosis begins when membrane receptors bind to the pathogen. The pathogen is 
opsonized with pattern recognition receptors, opsonization with antibodies and 
complement fragments bind more specifically to receptors on phagocytes, this enhances 
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internalization into a membrane bound vesicle called a phagosome which fuses with 
lysosomes to form a phagolysosome(Abbas, Abdul K, Litchman, Andrew H, Pillai, 2016). 
 
Enzymes are activated in the phagolysosome, an enzyme called the phagocyte oxidase 
converts molecular oxygen to superoxides anion and free radicals, which are reactive 
oxygen species (ROS), this process is called an oxidative burst. The free radicals and ROS 
are toxic to the pathogens ingested. Another enzyme, the inducible nitric oxide synthase 
(iNOS), catalyzes the conversion of arginine to nitric oxide (NO), which is microbicidal in 
nature. Lysosomal proteases are enzymes that break down proteins. These enzymes do not 
affect the phagocyte itself, only the ingested microbes. Neutrophils have other mechanisms 
for microbial killing. It can release microbiocidal granules into the extracellular matrix and 
upon the death of a neutrophil release their nuclear contents which form neutrophil 
extracellular traps (NETs), a network of chromatin. The NETs trap and kill bacterial and 
fungi(Abbas, Abdul K, Litchman, Andrew H, Pillai, 2016),(Segal, 2005). 
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METHODS 
Animals 
Adult female ICR mice (from Harlan-Sprague Dawley, Inc., Indianapolis, IN) 
were used. 
Mice were acclimated to our housing room for at least 5 days before being 
sacrificed. This was a temperature-controlled room with 12 hours light- 12 hours 
dark diurnal cycle. They were provided food and water ad libitum for the entire 
duration of the experiment. The experiments were approved by Boston University 
Animal Care and Use Committee. 
 
Plasma Enhanced Killing assay protocol  
The assay was performed using thioglycollate elicited neutrophils/macrophages, and 
enteric bacteria from a normal naïve mouse, so that the cells and bacteria were 
consistent. The only assay variable was the source of the plasma, which came from 
other individual mice.   
Preparing peritoneal cells 
The naïve mice to be used were injected intraperitoneally with 3.0ml of 3% warm 
thioglycollate, the polymorphonuclear (PMN) cells were recovered 4-6 hours later or 
72 – 96 hours for macrophages by peritoneal lavage with 5ml of warm HBSS 
(without calcium, magnesium and phenol red). 
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Preparing Bacteria 
A naïve mouse was sacrificed and about 2cm of the cecum was excised. The cecum 
was then ground and homogenized using a Grinder (Brinkmann, Polytron PT 3000) 3 
times for 10s in 2.0 ml HBSS on ice. The solid contents were removed from the 
ground cecum using a cell strainer (70µm) while washing with an additional 3.0ml of 
HBSS. The filtrate was then centrifuged at 2500g for 5 minutes. The supernatant was 
suctioned off and the pellet was resuspended with HBSS and quantified using the 
McFarland standard with measurement at 600/565 nm. Initial experiments used an  
OD of 1.3 which was equivalent to 5 x 109 CFU/ml. The actual bacterial 
concentration was about 1/50 of this ( 1 x 108 CFU/ml). Later experiments used an 
OD of approximately 1.0. The number of bacteria per tube for opsonization was 7.5 x 
106 CFU/ml. The colony forming units (CFU) were verified by plating aliquots.  
    
 
 
 
 
 
 
 
Figure 2. An aerobic culture plate is on the left and an anaerobic culture plate on 
the right with colonies of bacterial after the PEK assay was performed 
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Harvesting immune cells 
The phagocytic cells were harvested via a peritoneal lavage using 5ml of warm HBSS 
from a thioglycollate injected mouse and then placed on ice. The lavage was spun 
down (800g for 5 minutes). Red blood cells were removed by adding 1.0ml of Milli Q 
water to the cell pellet to resuspend the cells for 30 seconds and then 1.0 ml of 2X 
saline was added. The mixture was then spun down again at 800g for 5 minutes, the 
pellet was resuspended in 1.0ml of HBSS. The cells were counted using the 
Beckman-Coulter particle counter model ZF (Coulter Electronics, Hialeah, Fl). 
Cytospin slides were made to verify cells recovered from the peritoneal lavage.  
      
 
Figure 3. Cytospin of peritoneal lavage after 72 hours of thioglycollate injection 
showing predominantly macrophages 
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Figure 4. Cytospin of peritoneal lavage after 4 hours of thioglycollate injection 
showing predominantly neutrophils  
PEK assay 
To perform the plasma enhanced killing (PEK) assay, 25µl of plasma was diluted to 
50% with 25µl of HBSS and this was incubated with an equal volume of bacteria 
(1.75 x105 CFU) at 37°C with continuous shaking for 1 hour to opsonize the bacteria. 
The opsonization  
process was stopped by putting the mixture on ice for 1 hour. The thioglycollate 
elicited neutrophils/macrophages (1.75 x 104) were mixed with the opsonized bacteria 
and incubated at 37°C in a shaker for 1hour. The mixture was plated on blood agar 
plates (Fisher Scientific) in duplicates. Plates were incubated at 37° C in aerobic or 
anaerobic conditions for 20 hours and then the number of residual bacteria was 
counted. PEK was calculated by the following equation: 
PEK = [1/log10 (N)] x 100 
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Where N = number of recovered bacteria. A lower number of recovered bacteria 
meant better bacterial killing which in turn lead to a higher PEK value. To state this 
more directly, a higher PEK number indicated better killing. 
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RESULTS 
The experiment focused on using macrophages as the phagocyte of choice based on 
previous work done in the Remick lab which supports macrophages as the cells that bind 
to IgG in plasma to either facilitate or inhibit bacterial killing. All the plasma used were 
from individual mice. The cells used in Table 2 were macrophages harvested 36 hours 
after the mouse was injected intraperitoneally with thiogylcollate.  
Table 2. Number of recovered bacteria on aerobic and anaerobic blood agar from 
experiment where EDTA was used as anticoagulant and macrophages were the 
phagocytic cell used 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Dilution Aerobic Anaerobic Total CFU/ml 
Bacteria+Plasma 1.00E-03 102 TNTC  TNTC   
  1.00E-04 0 0 0    
Mouse 1 1.00E-03 95 TNTC     
  1.00E-04 0 0  0   
Mouse 2 1.00E-03 34 TNTC     
  1.00E-04 0 0  0   
Mouse 3 1.00E-03 4 TNTC  TNTC   
  1.00E-04 3 41     
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The macrophages were confirmed by plating cytospin of the lavage which showed that 
over 80% of the cells on the slide were macrophages as seen in Figure 2. Three and four 
serial dilutions used showed that the third serial dilution produced bacterial growth that 
was too numerous to count (TNTC) as shown in Tables 2 - 4. This was done as the 
process of experimentation was being revised.  Serial dilutions were made up to five 
times and the fourth and fifth plated.  In Table 3 below the fourth serial dilution produced 
bacterial counts after the PEK assay that were significant compared to Table 2. 
Table 3. Number of recovered bacteria from experiment where EDTA was used as 
anticoagulant and macrophages were the phagocytic cell used 
  Dilution Aerobic Anaerobic Total CFU/ml 
Bacteria+Plasma 1.00E-03 TNTC TNTC  TNTC TNTC  
  1.00E-04 75 220 295 2.95E+07 
Mouse 1 1.00E-03 TNTC TNTC TNTC  TNTC  
  1.00E-04 78 234 312 3.12E+07 
Mouse 2 1.00E-03 TNTC TNTC TNTC   TNTC 
  1.00E-04 86 301 387 3.87E+07 
Mouse 3 1.00E-03 TNTC TNTC TNTC  TNTC  
  1.00E-04 84 219 303 3.03E+07 
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Table 4. Number of recovered bacteria from experiment where EDTA was 
used as anticoagulant and macrophages were the phagocytic cell used 
 
 
Tables 5 and 6 show results which reflect very little growth on the blood agar. Only a 
handful of plating showed any growth at all and of the ones that showed growth very few 
showed significant growth over a CFU count of 30. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Dilution Aerobic Anaerobic Total CFU/ml 
Bacteria+Plasma 1.00E-03 272 TNTC TNTC TNTC  
  1.00E-04 30 177 207 2.07E+07 
Mouse 1 1.00E-03 333 TNTC TNTC TNTC  
  1.00E-04 125 33 158 1.58E+07 
Mouse 2 1.00E-03 215 TNTC TNTC TNTC  
  1.00E-04 1 39 40 4.00E+06 
Mouse 3 1.00E-03 270 TNTC TNTC TNTC  
  1.00E-04 0 33 33 3.30E+06 
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Table 5. Number of recovered bacteria from experiment where heparin was used as 
anticoagulant and neutrophils were the phagocytic cell used 
 
  Dilution Aerobic Anaerobic Total CFU/ml 
Bacteria+Plasma 1.00E-04 0 0     
  1.00E-05 0 0     
Mouse 1(51) 1.00E-04 0 43 43 4.30E+06 
  1.00E-05 0 0     
Mouse 2 1.00E-04 0 29 29 2.90E+06 
  1.00E-05 0 1     
Mouse 3 1.00E-04 0 18 18   
  1.00E-05 0 0     
Mouse 4 1.00E-04 3 39 39 3.90E+06 
  1.00E-05 1 1     
Mouse 5 1.00E-04 1 12     
  1.00E-05 0 0     
Mouse 6 1.00E-04 0 16     
  1.00E-05 0 0     
Mouse 7 1.00E-04 0 55 55 5.50E+06 
  1.00E-05 0 2     
Mouse 9 1.00E-04 0 25    
  1.00E-05 0 0     
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Table 6. Number of recovered bacteria from experiment where heparin was used as 
anticoagulant and neutrophils were the phagocytic cell used 
 
  Dilution Aerobic Anaerobic Total CFU/ml 
Bacteria+Plasma 1.00E-04 0 0     
  1.00E-05 0 0     
Mouse 1 1.00E-04 71 224 295 2.95E+07 
  1.00E-05 27 50 77 7.70E+07 
Mouse 2 1.00E-04 0 0     
  1.00E-05 0 0     
Mouse 3 1.00E-04 0 0     
  1.00E-05 0 0     
Mouse 4 1.00E-04 0 19     
  1.00E-05 0 0     
Mouse 5 1.00E-04 4 26     
  1.00E-05 0 0     
Mouse 6 1.00E-04 0 0     
  1.00E-05 0 0     
Mouse 7 1.00E-04 252 TNTC     
  1.00E-05 8 23 31 3.10E+07 
 
 
In figure 5 is shown the result of four different experiments where the number of 
individual mice plasma used was 29 each represented by triangles with the exception of 
the 2 mice which had higher CFUs indicating that these mice had inhibitory IgG in their 
plasma. The distribution of CFU counted after 20 hours incubation showed most of the 
plasma having a tendency for killing. The plasma used in all the experiments involving 
macrophages was collected with Ethylenediaminetetraacetic acid (EDTA) as the 
anticoagulant used.  
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Figure 5 Plot of the results for recovered bacteria from experiments using mice 
plasma collected with EDTA and macrophages  
Further experimentation was done using neutrophils as the phagocytic cell of choice, the 
results are displayed in figure 6. The neutrophils were confirmed by the plating of 
cytospin which showed over 80% neutrophils as shown in figure 4 above. The plasma 
collected from the mice was anticoagulated with heparin. The results of Figure 6 are 
more spread out compared to figure 5 with a cluster separated towards the bottom of the 
figure reflecting a killing tendency of the plasma also about 9 mice in figure 2 had higher 
CFU’s which would imply that the plasma of these mice would most likely contain 
elevated amounts of inhibitory IgG 
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Figure 6. Plot of results from recovered bacteria in experiment using mice plasma 
collected with heparin and the use of neutrophils 
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DISCUSSION 
 
This study sought to show the presence of inhibitory IgG in mouse plasma which binds 
preferentially to antigenic sites of bacteria and thereby inhibiting their opsonization and 
killing.(Moitra et al., 2012) The results of this study have shown that we were able to 
identify individual mice plasma that exhibited characteristics that would indicate the 
presence of inhibitory IgG in their plasma. The results shown from figure 6 shows 9 
individual mice that had elevated CFU counts after plating and incubation for 20 hours. 
This also indicates that the plasma in these mice would limit the killing of bacteria and so 
in the event of sepsis these mice would be more likely to succumb to the infection and 
die. Also, in figure 6 was an observation of a cluster of results that showed separation at 
the bottom of the graph. The plasma of these mice would suggest that they had the 
capability to overcome the inhibition of the IgG and thus in the event of sepsis would be 
likely to kill bacteria better. Earlier experiments by this lab suggest that naturally 
occurring IgG and IgM play an essential role in facilitating protection against bacterial 
infection before the onset of sepsis(Moitra et al., 2012). 
 
A paper published in the journal of Immunology in 2011 by Ray et al showed the 
presence of an inhibitory IgG that hindered the killing of group B meningococci by 
human(Ray, Lewis, Gulati, Rice, & Ram, 2011), (Moitra et al., 2012). Ray et al 
demonstrated that the Fc region of the IgG was necessary for its blocking activity. The 
blocking a posttranslational modification of glycosylation, this may suggest that the 
  28  
  
ability to overcome the effects of inhibitory IgG maybe dictated by posttranslational 
modifications not yet identified. This could be the reason why some mice would have 
elevated levels or inhibitory IgG and others will not. This may also translate to humans 
and help predict individuals more susceptible to succumb to sepsis and other infections. 
 
Further studies need to be conducted on the plasma of the mice with inhibitory IgG so as 
to map out the pathway of inhibition and determine if posttranslational modification plays 
a role and what triggers may be responsible for this. The difference in results between the 
plasma collected with EDTA and that with heparin may come down to understanding 
what impact calcium may have on the bactericidal ability of plasma. A comparison of the 
constitution of both plasmas after the PEK experimentation would be ideal. 
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